Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5775) 5775
Book Chapter (51) 51
Magazine Article (22) 22
Newspaper Article (16) 16
Newsletter (7) 7
Book / eBook (3) 3
Conference Proceeding (1) 1
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (5573) 5573
humans (5559) 5559
testicular neoplasms - drug therapy (3975) 3975
science & technology (2800) 2800
adult (2780) 2780
life sciences & biomedicine (2768) 2768
testicular neoplasms - pathology (1846) 1846
antineoplastic combined chemotherapy protocols - therapeutic use (1652) 1652
biological and medical sciences (1590) 1590
middle aged (1589) 1589
medical sciences (1566) 1566
oncology (1452) 1452
testicular neoplasms - surgery (1251) 1251
adolescent (1204) 1204
chemotherapy (1174) 1174
neoplasms, germ cell and embryonal - drug therapy (1075) 1075
cisplatin - administration & dosage (1032) 1032
tumors (971) 971
testicular cancer (904) 904
female (862) 862
prognosis (836) 836
combined modality therapy (835) 835
abridged index medicus (823) 823
testicular neoplasms - therapy (776) 776
bleomycin - administration & dosage (765) 765
cancer (736) 736
antineoplastic agents - therapeutic use (717) 717
urology & nephrology (699) 699
neoplasm staging (687) 687
pharmacology. drug treatments (682) 682
treatment outcome (643) 643
etoposide - administration & dosage (628) 628
gynecology. andrology. obstetrics (589) 589
teratoma - drug therapy (585) 585
follow-up studies (569) 569
aged (567) 567
antineoplastic combined chemotherapy protocols - adverse effects (550) 550
male genital diseases (525) 525
antineoplastic agents (524) 524
orchiectomy (512) 512
cisplatin - therapeutic use (502) 502
neoplasms, germ cell and embryonal - pathology (495) 495
cisplatin - adverse effects (493) 493
retrospective studies (459) 459
testicular neoplasms - radiotherapy (459) 459
child (455) 455
lymph node excision (439) 439
testicular neoplasms - mortality (438) 438
neoplasm metastasis (433) 433
lymphatic metastasis (431) 431
germinoma - drug therapy (415) 415
seminoma - drug therapy (413) 413
vinblastine - administration & dosage (409) 409
time factors (407) 407
drug therapy, combination (400) 400
risk factors (389) 389
neoplasms, germ cell and embryonal - surgery (378) 378
testicular neoplasms - diagnosis (375) 375
dysgerminoma - drug therapy (361) 361
antineoplastic agents - adverse effects (344) 344
young adult (343) 343
animals (337) 337
bleomycin - adverse effects (329) 329
child, preschool (325) 325
antineoplastic agents - administration & dosage (318) 318
antineoplastic combined chemotherapy protocols - administration & dosage (305) 305
cisplatin (295) 295
care and treatment (292) 292
chemotherapy, adjuvant (275) 275
testicular neoplasms (273) 273
testicular neoplasms - complications (270) 270
bleomycin - therapeutic use (269) 269
testicular neoplasms - genetics (267) 267
seminoma - pathology (260) 260
surgery (254) 254
drug administration schedule (249) 249
testicular neoplasms - blood (248) 248
disease-free survival (245) 245
survival rate (241) 241
teratoma - pathology (236) 236
lung neoplasms - drug therapy (235) 235
lung neoplasms - secondary (233) 233
germ cell tumors (229) 229
testicular neoplasms - metabolism (227) 227
infant (224) 224
retroperitoneal space (224) 224
cyclophosphamide - administration & dosage (223) 223
seminoma (223) 223
salvage therapy (217) 217
teratoma - surgery (215) 215
urology (215) 215
medicine & public health (208) 208
neoplasms - drug therapy (208) 208
neoplasms, germ cell and embryonal - therapy (205) 205
research (205) 205
neoplasms, germ cell and embryonal - secondary (202) 202
clinical trials as topic (201) 201
metastasis (199) 199
remission induction (197) 197
ovarian neoplasms - drug therapy (196) 196
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5111) 5111
German (273) 273
Japanese (247) 247
French (142) 142
Spanish (68) 68
Russian (64) 64
Italian (36) 36
Polish (33) 33
Chinese (21) 21
Hungarian (20) 20
Dutch (17) 17
Portuguese (15) 15
Danish (7) 7
Czech (6) 6
Norwegian (6) 6
Slovak (5) 5
Serbian (4) 4
Bulgarian (3) 3
Swedish (3) 3
Croatian (2) 2
Finnish (2) 2
Romanian (2) 2
Turkish (2) 2
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial
by Fizazi, Karim, Prof and Pagliaro, Lance, Prof and Laplanche, Agnes, MD and Fléchon, Aude, MD and Mardiak, Josef, Prof and Geoffrois, Lionnel, MD and Kerbrat, Pierre, Prof and Chevreau, Christine, MD and Delva, Remy, MD and Rolland, Frederic, MD and Theodore, Christine, MD and Roubaud, Guilhem, MD and Gravis, Gwenaëlle, MD and Eymard, Jean-Christophe, MD and Malhaire, Jean-Pierre, MD and Linassier, Claude, Prof and Habibian, Muriel and Martin, Anne-Laure and Journeau, Florence and Reckova, Maria, MD and Logothetis, Christopher, Prof and Culine, Stephane, Prof
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 13, pp. 1442 - 1450
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Testicular Neoplasms - mortality | Prognosis | Follow-Up Studies | Peritoneal Neoplasms - blood | Humans | Middle Aged | Male | Mediastinal Neoplasms - mortality | Neoplasms, Germ Cell and Embryonal - blood | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Young Adult | Mediastinal Neoplasms - drug therapy | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Oxaliplatin | Chorionic Gonadotropin - blood | Adult | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Paclitaxel - administration & dosage | Precision Medicine | alpha-Fetoproteins - metabolism | Peritoneal Neoplasms - pathology | Lenograstim | Mediastinal Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - mortality | Etoposide - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Peritoneal Neoplasms - mortality | Recombinant Proteins - administration & dosage | Biomarkers, Tumor - blood | Ifosfamide - administration & dosage | International Agencies | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Adolescent | Aged | Neoplasm Staging | Testicular Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - pathology | Granulocyte Colony-Stimulating Factor - administration & dosage | Chemotherapy | Tumors | Cancer | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Germ cell tumors
by Raghavan, Derek
2003, American Cancer Society atlas of clinical oncology, ISBN 9781550090826
Testis | Germ cells | pathology | Testicular Neoplasms | Neoplasms | Tumors
eBook
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation
by Zschäbitz, Stefanie and Lasitschka, Felix and Hadaschik, Boris and Hofheinz, Ralf-Dieter and Jentsch-Ullrich, Kathleen and Grüner, Marcus and Jäger, Dirk and Grüllich, Carsten
European journal of cancer (1990), ISSN 0959-8049, 2017, Volume 76, pp. 1 - 7
Hematology, Oncology and Palliative Medicine | Germ cell cancer | Immunotherapy | PD-L1 | Checkpoint inhibition | Platinum refractory disease | Testicular cancer | PD-1 | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Seminoma - diagnostic imaging | Teratoma | Endodermal Sinus Tumor - drug therapy | Compassionate Use Trials | Choriocarcinoma, Non-gestational - secondary | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Tomography, X-Ray Computed | Transplantation, Autologous | Testicular Neoplasms - pathology | Seminoma - metabolism | Stem Cell Transplantation | Mediastinal Neoplasms - drug therapy | Lung Neoplasms - secondary | Adult | Neoplasms, Germ Cell and Embryonal - drug therapy | Retrospective Studies | Choriocarcinoma, Non-gestational - metabolism | Endodermal Sinus Tumor - secondary | Endodermal Sinus Tumor - diagnostic imaging | Ifosfamide - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Seminoma - drug therapy | Testicular Neoplasms - metabolism | Programmed Cell Death 1 Receptor - metabolism | Etoposide - therapeutic use | Neoplasms, Germ Cell and Embryonal - metabolism | Treatment Outcome | Choriocarcinoma, Non-gestational - diagnostic imaging | Endodermal Sinus Tumor - metabolism | Neoplasms, Germ Cell and Embryonal - diagnostic imaging | Cisplatin - therapeutic use | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Lung Neoplasms - diagnostic imaging | Mediastinal Neoplasms - metabolism | Platinum Compounds - administration & dosage | Seminoma - secondary | Choriocarcinoma, Non-gestational - drug therapy | Neoplasms, Germ Cell and Embryonal - secondary | Viral antibodies | Medical research | Relapse | Chemotherapy | Stem cells | Medicine, Experimental | Antibodies | Transplantation | Metastasis | Diseases | Cancer | Apoptosis | Autografts | Cell survival | PD-1 protein | Toxicity | Mortality | Clinical trials | Stem cell transplantation | Patients | Metastases | Inhibitors | Immune checkpoint | Platinum | Cell death | PD-L1 protein | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Resection of Primary Mediastinal Non-Seminomatous Germ Cell Tumors: A 28-Year Experience at Memorial Sloan-Kettering Cancer Center
by Sarkaria, Inderpal S and Bains, Manjit S and Sood, Shelly and Sima, Camelia S and Reuter, Victor E and Flores, Raja M and Motzer, Robert J and Bosl, George J and Rusch, Valerie W
Journal of thoracic oncology, ISSN 1556-0864, 07/2011, Volume 6, Issue 7, pp. 1236 - 1241
Mediastinal Mass | Tumor Markers | Surgery | Germ Cell Tumor | Neoplasm, Residual - pathology | Lung Neoplasms - drug therapy | Follow-Up Studies | Neoplasm, Residual - surgery | Humans | Middle Aged | Bone Neoplasms - secondary | Neoplasm Recurrence, Local - drug therapy | Male | Teratoma - surgery | Neoplasm Recurrence, Local - surgery | Brain Neoplasms - surgery | Neoplasm Recurrence, Local - pathology | Young Adult | Brain Neoplasms - secondary | Mediastinal Neoplasms - drug therapy | Lung Neoplasms - secondary | Time Factors | Adult | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Retrospective Studies | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Mediastinal Neoplasms - surgery | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Survival Rate | Treatment Outcome | Bone Neoplasms - surgery | Brain Neoplasms - drug therapy | Teratoma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Teratoma - drug therapy | Adolescent | Neoplasm, Residual - drug therapy | Lung Neoplasms - surgery | Neoplasms, Germ Cell and Embryonal - surgery | Neoplasm Staging | Neoplasms, Germ Cell and Embryonal - pathology | Testicular Neoplasms
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Nonchoriocarcinomatous Trophoblastic Tumors of the Testis: The Widening Spectrum of Trophoblastic Neoplasia
by Idrees, Muhammad T and Kao, Chia-Sui and Epstein, Jonathan I and Ulbright, Thomas M
The American journal of surgical pathology, ISSN 0147-5185, 11/2015, Volume 39, Issue 11, pp. 1468 - 1478
Choriocarcinoma | Germ cell tumor | Epithelioid trophoblastic tumor | Testicular neoplasms | Placental site trophoblastic tumor | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Immunohistochemistry | Neoplasms, Complex and Mixed - secondary | Testicular Neoplasms - mortality | Adenocarcinoma - pathology | Trophoblastic Neoplasms - pathology | Neoplasms, Complex and Mixed - drug therapy | Trophoblastic Tumor, Placental Site - drug therapy | Adenocarcinoma - classification | Humans | Male | Neoplasms, Complex and Mixed - mortality | Testicular Neoplasms - pathology | Young Adult | Neoplasms, Complex and Mixed - classification | Time Factors | Trophoblastic Neoplasms - mortality | Adult | Female | Adenocarcinoma - chemistry | Testicular Neoplasms - classification | Epithelioid Cells - pathology | Trophoblastic Tumor, Placental Site - pathology | Trophoblastic Tumor, Placental Site - secondary | Biomarkers, Tumor - analysis | Trophoblastic Neoplasms - chemistry | Treatment Outcome | Trophoblastic Tumor, Placental Site - mortality | Epithelioid Cells - chemistry | Trophoblastic Tumor, Placental Site - classification | Adenocarcinoma - drug therapy | Trophoblastic Neoplasms - classification | Pregnancy | Neoplasms, Complex and Mixed - chemistry | Trophoblastic Tumor, Placental Site - chemistry | Testicular Neoplasms - drug therapy | Trophoblastic Neoplasms - drug therapy | Biopsy | Trophoblastic Neoplasms - secondary | Neoplasms, Complex and Mixed - pathology | Testicular Neoplasms - chemistry | Adenocarcinoma - mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Administration of chemotherapy in patients on dialysis
by Kuo, James C and Craft, Paul S
Anti-cancer drugs, ISSN 0959-4973, 08/2015, Volume 26, Issue 7, pp. 779 - 784
Drug dosage calculations | End-stage renal disease | Chemotherapy | Drug adverse events | Haemodialysis | Peritoneal dialysis | Pharmacology & Pharmacy | Oncology | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Neoplasms, Squamous Cell - complications | Skin Neoplasms - drug therapy | Humans | Middle Aged | Male | Small Cell Lung Carcinoma - complications | Small Cell Lung Carcinoma - drug therapy | Testicular Neoplasms - complications | Neoplasms - complications | Neoplasms, Squamous Cell - drug therapy | Female | Neoplasms, Germ Cell and Embryonal - complications | Neoplasms, Germ Cell and Embryonal - drug therapy | Liver Neoplasms - secondary | Liver Neoplasms - drug therapy | Lung Neoplasms - complications | Neoplasms - drug therapy | Kidney Failure, Chronic - therapy | Skin Neoplasms - complications | Parotid Neoplasms - complications | Carcinoma, Squamous Cell - drug therapy | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Squamous Cell - complications | Kidney Failure, Chronic - complications | Parotid Neoplasms - pathology | Aged | Parotid Neoplasms - drug therapy | Renal Dialysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors
by Einhorn, Lawrence H and Williams, Stephen D and Chamness, Amy and Brames, Mary J and Perkins, Susan M and Abonour, Rafat
The New England journal of medicine, ISSN 0028-4793, 07/2007, Volume 357, Issue 4, pp. 340 - 348
Biological and medical sciences | General aspects | Medical sciences | Testicular Neoplasms - mortality | Prognosis | Follow-Up Studies | Humans | Middle Aged | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Male | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Adult | Neoplasms, Germ Cell and Embryonal - drug therapy | Retrospective Studies | Neoplasms, Germ Cell and Embryonal - mortality | Testicular Neoplasms - therapy | Neoplasm Recurrence, Local - therapy | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy | Remission Induction | Algorithms | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Neoplasms, Germ Cell and Embryonal - therapy | Neoplasms, Germ Cell and Embryonal - secondary | Chemotherapy | Dosage and administration | Drug therapy | Testicular cancer | Germ cell tumors | Cancer | Bone marrow | Transplants & implants | Stem cells | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors
by Nieto, Y and Tu, S. -M and Bassett, R and Jones, R. B and Gulbis, A. M and Tannir, N and Kingham, A and Ledesma, C and Margolin, K and Holmberg, L and Champlin, R and Pagliaro, L
Annals of oncology, ISSN 0923-7534, 10/2015, Volume 26, Issue 10, pp. 2125 - 2132
Life Sciences & Biomedicine | Oncology | Science & Technology | Testicular Neoplasms - mortality | Prognosis | Follow-Up Studies | Humans | Middle Aged | Retroperitoneal Neoplasms - therapy | Salvage Therapy | Drug Resistance, Neoplasm | Male | Mediastinal Neoplasms - mortality | Transplantation, Autologous | Neoplasm Recurrence, Local - mortality | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Neoplasm Recurrence, Local - pathology | Young Adult | Retroperitoneal Neoplasms - mortality | Neoplasm Metastasis | Mediastinal Neoplasms - therapy | Adult | Female | Retroperitoneal Neoplasms - pathology | Child | Neoplasms, Germ Cell and Embryonal - mortality | Testicular Neoplasms - therapy | Bevacizumab - administration & dosage | Neoplasm Invasiveness | Deoxycytidine - administration & dosage | Neoplasm Recurrence, Local - therapy | Carboplatin - administration & dosage | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Survival Rate | Combined Modality Therapy | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Adolescent | Aged | Neoplasm Staging | Neoplasms, Germ Cell and Embryonal - pathology | Neoplasms, Germ Cell and Embryonal - therapy | Deoxycytidine - analogs & derivatives | germ-cell tumors | autologous transplantation | docetaxel | bevacizumab | gemcitabine | Original | high-dose chemotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Genomic evolution and chemoresistance in germ-cell tumours
by Taylor-Weiner, Amaro and Zack, Travis and O'Donnell, Elizabeth and Guerriero, Jennifer L and Bernard, Brandon and Reddy, Anita and Han, G. Celine and Aldubayan, Saud and Amin-Mansour, Ali and Schumacher, Steven E and Litchfield, Kevin and Turnbull, Clare and Gabriel, Stacey and Beroukhim, Rameen and Getz, Gad and Carter, Scott L and Hirsch, Michelle S and Letai, Anthony and Sweeney, Christopher and Van Allen, Eliezer M
Nature (London), ISSN 0028-0836, 11/2016, Volume 540, Issue 7631, pp. 114 - 118
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Proto-Oncogene Proteins p21(ras) - genetics | Genomics | Humans | Drug Resistance, Neoplasm | Male | Neoplasms, Germ Cell and Embryonal - genetics | Phylogeny | Loss of Heterozygosity | Testicular Neoplasms - pathology | Tumor Suppressor Protein p53 - genetics | Neoplasms, Germ Cell and Embryonal - drug therapy | Testicular Neoplasms - genetics | Testicular Neoplasms - metabolism | Nanog Homeobox Protein - deficiency | Neoplasms, Germ Cell and Embryonal - metabolism | Mitochondria - metabolism | Transcriptome - genetics | Disease Progression | Genome, Human - genetics | Neoplasm Metastasis - genetics | Exome - genetics | Testicular Neoplasms - drug therapy | Neoplasm Metastasis - pathology | Teratoma - genetics | Mutation | Octamer Transcription Factor-3 - deficiency | Neoplasms, Germ Cell and Embryonal - pathology | Apoptosis | Evolution, Molecular | Genetic aspects | Tumors | Chemotherapy | Cell cycle | Phylogenetics | Metastasis | Drug resistance | Chromosomes | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers
by Noel, Elodie E and Yeste-Velasco, Marc and Mao, Xueying and Perry, Jackie and Kudahetti, Sakunthala C and Li, Ningfeng F and Sharp, Swee and Chaplin, Tracy and Xue, Liyan and McIntyre, Alan and Shan, Ling and Powles, Thomas and Oliver, R. Tim D and Young, Bryan D and Shipley, Janet and Berney, Daniel M and Joel, Simon P and Lu, Yong-Jie
The American journal of pathology, ISSN 0002-9440, 2010, Volume 176, Issue 6, pp. 2607 - 2615
Pathology | Life Sciences & Biomedicine | Science & Technology | Gynecology. Andrology. Obstetrics | Investigative techniques, diagnostic techniques (general aspects) | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Cyclin D1 - metabolism | RNA, Small Interfering - genetics | Cell Proliferation | Humans | Ovarian Neoplasms - pathology | Ovarian Neoplasms - physiopathology | Male | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Prostatic Neoplasms - physiopathology | Testicular Neoplasms - pathology | Neoplasms, Germ Cell and Embryonal - physiopathology | Microarray Analysis | Testicular Neoplasms - physiopathology | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Cell Survival | Drug Resistance, Neoplasm - genetics | Cisplatin - therapeutic use | Comparative Genomic Hybridization | Cyclin D1 - genetics | Testicular Neoplasms - drug therapy | Cell Line, Tumor | Neoplasms, Germ Cell and Embryonal - pathology | RNA, Small Interfering - metabolism | Index Medicus | Abridged Index Medicus | Regular
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Immunotherapy in uropathology
by Verkarre, Virginie and Roussel, Hélène and Granier, Clémence and Tartour, Eric and Allory, Yves
Annales de pathologie, ISSN 0242-6498, 02/2017, Volume 37, Issue 1, pp. 90 - 100
PD-L1 | Bladder cancer | Prostate cancer | Renal carcinoma | Immunotherapy | Testis cancer | Life Sciences & Biomedicine | Pathology | Science & Technology | Humans | Kidney Neoplasms - immunology | Neoplasm Proteins - immunology | Tumor Microenvironment | Male | Neoplasm Proteins - antagonists & inhibitors | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Molecular Targeted Therapy | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Urogenital Neoplasms - drug therapy | Kidney Neoplasms - therapy | Prostatic Neoplasms - drug therapy | Testicular Neoplasms - therapy | Urinary Bladder Neoplasms - drug therapy | B7-H1 Antigen - immunology | Urogenital Neoplasms - immunology | Testicular Neoplasms - immunology | B7-H1 Antigen - antagonists & inhibitors | Testicular Neoplasms - drug therapy | Antineoplastic Agents, Immunological - therapeutic use | Urogenital Neoplasms - therapy | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - immunology | Programmed Cell Death 1 Receptor - immunology | Kidney Neoplasms - drug therapy
Journal Article
Details down arrow